Telmisartan

most data

Also seen as: Micardis, Pritor, Kinzal, BIBR 277, telmi

The Dose Guy’s verdict
Sep 1, 2026
4 sources

When blood pressure climbs on cycle, this is the first thing people reach for, and they are right to. Telmisartan is a clean, well-tolerated ARB with decades of outcome data and a metabolic bonus the other blood-pressure drugs do not carry. One pill a day, predictable, and it gets out of the way. If your pressure is up, start here.

Would I take it?Yes, the community's default for a reason.

What it is

Telmisartan is an angiotensin II receptor blocker, an ARB, meaning it blocks the receptor that tells your blood vessels to squeeze. Vessels relax, blood pressure drops. What sets it apart for this crowd is a second trick: telmisartan partially activates PPAR-gamma, a metabolic receptor usually associated with insulin sensitizers. The blood-pressure fix is proven and substantial. The metabolic angle showed up in one small trial but did not survive pooling: across six MASLD trials, telmisartan produced no significant change in HOMA-IR or lipid profiles. Call it a plausible bonus, not a proven one.

The community adopted it because it works, it is gentle, and it does not mess with the things people care about on cycle.

What the research shows

The evidence base is large and old enough to be boring, which is exactly what you want from a blood-pressure drug:

ONTARGET: telmisartan matched ramipril on the cardiovascular composite, 16.7% versus 16.5% over a median 56 months, with cough at 1.1% versus 4.2% and angioedema at 0.1% versus 0.3%.NEJM 2008 · RCT · n=25620
Central systolic blood pressure fell 29.3 mmHg with telmisartan versus 17.2 mmHg with nebivolol at 12 weeks, between-group difference 12.7 mmHg, p=0.004.Am J Hypertens 2026 · open-label RCT · n=98
In diabetic hypertension, 12-week median HOMA-IR was 1.79 with telmisartan versus 3.45 with other antihypertensives, p=0.001.Indian J Med Res 2026 · open-label RCT · n=70
In patients uncontrolled on telmisartan 20 mg, adding S-amlodipine 2.5 mg dropped systolic pressure 16.97 mmHg versus 7.42 mmHg from doubling to 40 mg at 8 weeks.Drug Des Devel Ther 2026 · phase 3 RCT · n=108

Realistic protocols

Telmisartan is straightforward. Start at 40 mg when pressure creeps above range on cycle, and give it two to four weeks to see its full blood-pressure effect. Most people land there and stay. If 40 mg does not get you there, adding a low-dose calcium channel blocker like amlodipine often beats doubling the ARB. 80 mg is the ceiling and rarely the right move.

Take it with or without food, morning or evening. Potassium can rise on any ARB, so check it with your bloodwork. Lightheadedness in the first few days is the drug doing its job on a body that was running hot. Stay hydrated and stand up slowly until you adjust. If you are stacking telmisartan with other blood-pressure tools, be careful about going too low. Hypotension on a caloric deficit feels terrible.

Alcohol stacks hypotension on the lightheadedness telmisartan already causes early on. NSAIDs blunt the blood-pressure effect, so if you are popping ibuprofen regularly, your panel will not reflect what telmisartan is actually doing.

Some guys run telmisartan year-round through blast and cruise. Others bring it in only when pressure goes up and drop it when it normalizes. Both approaches work. Bloodwork drives the decision: if your pressure is in range without it, you do not need it. And if the same cycle that pushed your pressure also wrecked your lipids, rosuvastatin handles that side.

Start40 mg/dayOnce daily. Give it 2–4 weeks to see full effect.
Adjust80 mg/dayOnly if 40 mg does not reach target. Rarely needed.
On cycle40 mg/dayRun through any blast that pushes pressure. Drop when numbers normalize.
MonitoringsameBlood pressure, potassium, creatinine. Check when you check everything else.

Side effects

ARBs as a class are gentle, and telmisartan is among the gentler ones:

commonLightheadedness or dizziness when starting, the pressure adjusting. Usually passes within days. Hydration helps.
monitorPotassium can climb. Part of the ARB mechanism. Check it on your regular panel.
monitorDo not combine with another drug that blocks the renin-angiotensin system. ONTARGET tested the combination: renal dysfunction hit 13.5% versus 10.2% with ramipril alone, and the primary endpoint did not improve.

Where to buy

$5.10 / 80mg vial$0.064/mg
✓ verified Sep 12
$30 / unit
✓ verified Sep 12

Prices move. Links are affiliate links; they never change a ranking, and scores are set before the deal exists.